Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems, Inc.'s Q·Score is 6.2/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. Clean balance sheet with low leverage (0.0× debt-to-equity). Key area to monitor: consensus analyst target is below current price. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.

The consensus price target for INSP is $60.73, based on ratings from 15 Wall Street analysts. This is 17.3% below the current price of $73.45. Price targets are forward-looking estimates and not guarantees of future performance.

Inspire Medical Systems, Inc. (INSP) scores below peers on valuation metrics, trading above typical sector multiples. Its forward P/E ratio stands at 47.8×. The consensus analyst price target of $60.73 is 17% below the current price.

Inspire Medical Systems, Inc.'s next earnings report is expected on approximately November 2, 2026.

Inspire Medical Systems, Inc. has a net profit margin of 15.0%, which is solid for most industries. Its gross margin stands at 86.1%, indicating a high-margin business model.

Inspire Medical Systems, Inc. is reporting revenue declining 7.6% year-over-year.

Inspire Medical Systems, Inc. has a debt-to-equity ratio of 0.04×, reflecting a very low debt-to-equity ratio, signalling a conservatively financed balance sheet. Its current ratio is 8.55×, indicating comfortable short-term liquidity.